One global clinical trial testing astegolimab for moderate to severe COPD hit its main goal, but another did not, Genentech reports.| COPD News Today
More than half of MG patients in a study had fatigue and its severity correlated with disease worsening, crises, and delays in diagnosis.| Myasthenia Gravis News